Bioactive compounds of red wine production waste: health effects and benefits
DOI:
https://doi.org/10.66636/gmj.v1.i3.a191Keywords:
polyphenols, cardiovascular disease, resveratrol, grape pomace, grape by-products, wine by products, red wine, french paradox, endothelial function, antioxidant, flavonoidsAbstract
Cardiovascular disease remains the leading cause of global mortality, and there is continued interest in dietary compounds that reduce oxidative stress, chronic inflammation, endothelial dysfunction, and atherosclerotic progression. Red wine has been associated with a lower risk of cardiovascular disease — a phenomenon known as the "French paradox" — and most of its proposed benefits are attributed to polyphenolic constituents rather than ethanol. During vinification, large amounts of grape pomace, seeds, and skins are produced, and these winery by-products contain high concentrations of the same bioactive compounds found in wine. This narrative review summarises the evidence regarding the cardiovascular benefits of red wine polyphenols and wine production waste. Key bioactive constituents include quercetin, catechins, anthocyanins, flavonoids, resveratrol, and phenolic acids, which exhibit antioxidant, anti-inflammatory, anti-platelet, and vasoprotective actions. At the molecular level, they inhibit low-density lipoprotein oxidation, suppress NF-κB signalling and pro-inflammatory cytokine production, enhance endothelial nitric oxide synthase activity, and improve nitric oxide bioavailability. Evidence also indicates that red wine polyphenols influence gut microbiota composition and confer vascular protection via epigenetic and mitochondrial signalling pathways, extending their influence beyond direct radical scavenging. Despite promising preclinical and observational findings, translation into clinical practice remains limited by inconsistent dosing strategies, variable bioavailability, and confounding effects of ethanol exposure. Future research should focus on standardised clinical trials of dealcoholised wine and purified polyphenol extracts from grape by-products to identify safe, evidence-based cardiovascular interventions.
Keywords: red wine; polyphenols; cardiovascular disease; resveratrol; grape pomace; French paradox; endothelial function; wine by-products; antioxidant; flavonoids
References
1. Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med. 2018;378(25):e34. https://doi.org/10.1056/NEJMoa1800389
2. Snopek L, Mlcek J, Sochorova L, Baron M, Hlavacova I, Jurikova T, et al. Contribution of red wine consumption to human health protection. Molecules. 2018;23(7):1684. https://doi.org/10.3390/molecules23071684
3. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992;339(8808):1523–1526. https://doi.org/10.1016/0140-6736(92)91277-f
4. Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:d671. https://doi.org/10.1136/bmj.d671
5. Chiva-Blanch G, Urpi-Sarda M, Llorach R, et al. Differential effects of polyphenols and alcohol of red wine on the expression of adhesion molecules and inflammatory cytokines related to atherosclerosis. Circ Res. 2012;111(10):1013–1023. https://doi.org/10.1161/CIRCRESAHA.112.275636
6. Del Bo' C, Bernardi S, Cherchi S, et al. A single dose of a polyphenol-rich grape extract improves endothelial function in healthy individuals. Nutr Metab Cardiovasc Dis. 2021;31(3):948–956.
7. Diasamidze K, Kalandia A, Jafaridze I, Vanidze M. Saperavi wine by-products as a sustainable source of bioactive polyphenols: phenolic composition and antioxidant potential. Georgian Med J. 2026;1(2). https://doi.org/10.66636/gmj.v1.i2.a121
8. Joyner PM. Protein adducts and protein oxidation as molecular mechanisms of flavonoid bioactivity. Molecules. 2021;26(16):5102. https://doi.org/10.3390/molecules26165102
9. Castaldo L, Narváez A, Izzo L, et al. Red wine consumption and cardiovascular health. Molecules. 2019;24(19):3626. https://doi.org/10.3390/molecules24193626
10. Peña-Portillo GC, Acuña-Nelson SM, Bastías-Montes JM. From waste to wealth: exploring the bioactive potential of wine by-products — a review. Antioxidants (Basel). 2024;13(8):992. https://doi.org/10.3390/antiox13080992
11. Gál R, Halmosi R, Gallyas F, et al. Resveratrol and beyond: the effect of natural polyphenols on the cardiovascular system: a narrative review. Biomedicines. 2023;11(11):2888. https://doi.org/10.3390/biomedicines11112888
12. Liu Y, Luo J, Peng L, Zhang Q, Rong X, Luo Y, et al. Flavonoids: potential therapeutic agents for cardiovascular disease. Heliyon. 2024;10(12):e32563. https://doi.org/10.1016/j.heliyon.2024.e32563
13. Romain C, Gaillet S, Carillon J, Vidé J, Ramos J, Izard JC, et al. Vineatrol and cardiovascular disease: beneficial effects of a vine-shoot phenolic extract in a hamster atherosclerosis model. J Agric Food Chem. 2012;60(44):11029–11036. https://doi.org/10.1021/jf303549t
14. Mokni M, Hamlaoui S, Karkouch I, Amri M, Marzouki L, Limam F, et al. Resveratrol provides cardioprotection after ischemia/reperfusion injury via modulation of antioxidant enzyme activities. Iran J Pharm Res. 2013;12(4):867–875.
15. dos Santos KC, Braga CP, Barbanera PO, Seiva FRF, Fernandes Junior A, Fernandes AAH. Cardiac energy metabolism and oxidative stress biomarkers in diabetic rat treated with resveratrol. PLoS One. 2014;9(7):e102775. https://doi.org/10.1371/journal.pone.0102775
16. Brown K, Theofanous D, Britton RG, Aburido G, Pepper C, Sri Undru S, et al. Resveratrol for the management of human health: how far have we come? A systematic review of resveratrol clinical trials to highlight gaps and opportunities. Int J Mol Sci. 2024;25(2):747. https://doi.org/10.3390/ijms25020747
17. Bonnefont-Rousselot D. Resveratrol and cardiovascular diseases. Nutrients. 2016;8(5):250. https://doi.org/10.3390/nu8050250
18. Lopes JdC, Madureira J, Marçaca FMA, Cabo Verde S. Grape pomace: a review of its bioactive phenolic compounds, health benefits, and applications. Molecules. 2025;30(2):362. https://doi.org/10.3390/molecules30020362
19. Godos J, Romano GL, Gozzo L, et al. Resveratrol and vascular health: evidence from clinical studies and mechanisms of actions related to its metabolites produced by gut microbiota. Front Pharmacol. 2024;15:1368949. https://doi.org/10.3389/fphar.2024.1368949
20. Cooper KA, Chopra M, Thurnham DI. Wine polyphenols and promotion of cardiac health. Nutr Res Rev. 2004;17(1):111–129. https://doi.org/10.1079/NRR200482
21. Piano MR, Marcus GM, Aycock DM, et al. Alcohol use and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2025;152(1):e7–e21. https://doi.org/10.1161/CIR.0000000000001341
22. European Association for the Study of the Liver. EASL policy statement: reducing alcohol harms. 2023. https://easl.eu/publication/easl-policy-statement-reducing-alcohol-harms/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Sevi Gedikoglu

This work is licensed under a Creative Commons Attribution 4.0 International License.
This article is published open access under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence.
You are free to: share and adapt the work for any purpose, even commercially.
Conditions: provide appropriate credit to the authors and the Georgian Medical Journal (GMJ), link to the licence, and indicate if changes were made. Do not apply legal terms or technological measures that legally restrict others from doing anything the licence permits.
Licence: creativecommons.org/licenses/by/4.0 · Legal code: creativecommons.org/licenses/by/4.0/legalcode
Third-party material. Images or other content credited to a third party are not covered by CC BY 4.0; permission must be obtained from the rights holder for reuse beyond statutory exceptions.
Authors' rights. Authors retain copyright. First publication rights are granted to GMJ.
Data and code. Where provided, datasets or code may carry their own licences; please follow the licence stated in the article or repository record.




















